Baillie Gifford & Co’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-308
| Closed | -$465 | – | 362 |
|
|
2023
Q1 | $465 | Hold |
308
| – | – | ﹤0.01% | 450 |
|
|
2022
Q4 | $770 | Hold |
308
| – | – | ﹤0.01% | 481 |
|
|
2022
Q3 | $1K | Hold |
308
| – | – | ﹤0.01% | 481 |
|
|
2022
Q2 | $1K | Hold |
308
| – | – | ﹤0.01% | 485 |
|
|
2022
Q1 | $2K | Hold |
308
| – | – | ﹤0.01% | 490 |
|
|
2021
Q4 | $3K | Hold |
308
| – | – | ﹤0.01% | 492 |
|
|
2021
Q3 | $3K | Hold |
308
| – | – | ﹤0.01% | 486 |
|
|
2021
Q2 | $5K | Hold |
308
| – | – | ﹤0.01% | 464 |
|
|
2021
Q1 | $5K | Sell |
308
-18
| -6% | -$292 | ﹤0.01% | 434 |
|
|
2020
Q4 | $7K | Buy |
+326
| New | +$7K | ﹤0.01% | 404 |
|